FAQs

General/Corporate

PLx Pharma’s corporate headquarters is located at 9 Fishers Lane, Suite E, Sparta, NJ 07871

PLx Pharma was incorporated in Delaware on July 27, 2015.

PLx Pharma became a public company upon the closing of the merger with Dipexium Pharmaceuticals, Inc. in 2017.

PLx Pharma’s fiscal year is from January 1 to December 31.

PLx Pharma’s stock is traded as common stock on the NASDAQ Capital Markets under the ticker symbol “PLXP.”

Transfer Agent

The transfer agent and registrar for shares of PLx Pharma’s common stock is VStock Transfer, LLC.

Contact PLx Pharma’s transfer agent, VStock Transfer: 

VStock Transfer, LLC
18 Lafayette Pl
Woodmere, NY 11598
Phone:  212-828-8436
Toll-Free: 855-9VSTOCK
Email: 

Website: 

VStock Transfer is available to assist shareholders with stock transfers, changes of address, and replacement of lost stock certificates.

VStock Transfer, LLC
18 Lafayette Pl
Woodmere, NY 11598
Phone:  212-828-8436
Toll-Free: 855-9VSTOCK
Email:
info@vstocktransfer.com
Website:
https://www.vstocktransfer.com/

No, PLx Pharma does not have a direct stock purchase plan.

Auditor/Legal

PLx Pharma’s auditor is Marcum LLP (New York).

Olshan Frome Wolosky LLP (New York).

Company Inquiries

Within these provided links, you’ll find the latest corporate
Please visit the
Contact Us section of this site. You can also contact PLx Pharma Inc. at: 
Phone: (973) 409-6541
Fax: (973) 843-6300
Email: 
 

Please contact PLx Pharma’s investor relations department with any investor inquiries.
Janet M. Barth Vice President, Investor Relations & Corporate Communications
Email: jbarth@plxpharma.com
Phone: (908) 613-5820
or
Lisa M. Wilson, In-Site Communications, Inc.
Email: lwilson@insitecony.com
Phone: 212.452.2793

You can receive email updates  by signing up to be included on the PLx Pharma’s distribution list.